453 related articles for article (PubMed ID: 16137181)
1. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.
Ashavaid TF; Kondkar AA; Dherai AJ; Raghavan R; Udani SV; Udwadia ZF; Desai D
Mol Diagn; 2005; 9(2):59-66. PubMed ID: 16137181
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of cystic fibrosis in Indian patients--a preliminary report.
Ashavaid TF; Dherai AJ; Kondkar AA; Raghavan R; Udani SV; Udwadia ZF; Desai D
J Assoc Physicians India; 2003 Apr; 51():345-8. PubMed ID: 12723646
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive mutation screening in a cystic fibrosis center.
Wine JJ; Kuo E; Hurlock G; Moss RB
Pediatrics; 2001 Feb; 107(2):280-6. PubMed ID: 11158459
[TBL] [Abstract][Full Text] [Related]
5. Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease.
Friedman KJ; Heim RA; Knowles MR; Silverman LM
Hum Mutat; 1997; 10(2):108-15. PubMed ID: 9259194
[TBL] [Abstract][Full Text] [Related]
6. CFTR gene: molecular analysis in patients from South Brazil.
Streit C; Burlamaque-Neto AC; de Abreu e Silva F; Giugliani R; Saraiva Pereira ML
Mol Genet Metab; 2003 Apr; 78(4):259-64. PubMed ID: 12706377
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations.
Kambouris M; Banjar H; Moggari I; Nazer H; Al-Hamed M; Meyer BF
Eur J Pediatr; 2000 May; 159(5):303-9. PubMed ID: 10834512
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
11. [Mutations and polymorphisms in CFTR genes in infertile men with oligospermia or azoospermia].
Kusić J; Radojković D; Maletić V; Branković S; Savić A
Srp Arh Celok Lek; 2002; 130(1-2):1-6. PubMed ID: 12073281
[TBL] [Abstract][Full Text] [Related]
12. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
13. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.
Quint A; Lerer I; Sagi M; Abeliovich D
Am J Med Genet A; 2005 Jul; 136(3):246-8. PubMed ID: 15948195
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis in Brazilian cystic fibrosis patients reveals five novel mutations.
Bernardino AL; Ferri A; Passos-Bueno MR; Kim CE; Nakaie CM; Gomes CE; Damaceno N; Zatz M
Genet Test; 2000; 4(1):69-74. PubMed ID: 10794365
[TBL] [Abstract][Full Text] [Related]
15. The occurrence of various non-delta F508 CFTR gene mutations among Hungarian cystic fibrosis patients.
Nemeti M; Johnson JP; Papp Z; Louie E
Hum Genet; 1992 May; 89(2):245-6. PubMed ID: 1375186
[TBL] [Abstract][Full Text] [Related]
16. Screening for CF mutations in adult cystic fibrosis patients with a directed and optimized SSCP strategy.
Ravnik-Glavac M; Glavac D; Chernick M; di Sant'Agnese P; Dean M
Hum Mutat; 1994; 3(3):231-8. PubMed ID: 7517265
[TBL] [Abstract][Full Text] [Related]
17. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
[TBL] [Abstract][Full Text] [Related]
18. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I).
Onay T; Topaloglu O; Zielenski J; Gokgoz N; Kayserili H; Camcioglu Y; Cokugras H; Akcakaya N; Apak M; Tsui LC; Kirdar B
Hum Genet; 1998 Feb; 102(2):224-30. PubMed ID: 9521595
[TBL] [Abstract][Full Text] [Related]
20. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
